Globetrotting firms: Canada's health biotechnology collaborations with developing countries

Nature Biotechnology

Volumn 27, Issue 9, 2009, Pages 806-814

  Ray, Monali ^a   Daar, Abdallah S ^a   Singer, Peter A ^a   Thorsteinsdóttir, Halla ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECH FIRMS; FINANCIAL RESOURCES; KNOW-HOW;

DEVELOPING COUNTRIES; TECHNOLOGY TRANSFER;

BIOTECHNOLOGY;

BIODIVERSITY; BIOINFORMATICS; BIOTECHNOLOGY; CANADA; CHINA; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; ECONOMIC DEVELOPMENT; HEALTH SURVEY; HUMAN; INDIA; POPULATION SIZE; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; REVIEW; SOUTH AND CENTRAL AMERICA;

BIOTECHNOLOGY; CANADA; CHINA; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; DEVELOPING COUNTRIES; DRUG INDUSTRY; HUMANS; INDUSTRY; INSULIN; INTERNATIONAL COOPERATION; RESEARCH;

EID: 70249102136     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0909-806     Document Type: Review

References (24)

1. Thorsteinsdóttir, H., Quach, u., Daar, a.S. & Singer, P.a. Conclusions: promoting biotechnology innovation in developing countries. Nat. Biotechnol. 22 (suppl.), DC48-DC52 (2004).
2. frew, S.E. et al. India's health biotech sector at a crossroads. Nat. Biotechnol. 25, 403-417 (2007)
3. frew, S.E. et al. Chinese health biotech and the three-billion patient market. Nat. Biotechnol. 26, 37-53 (2008).
4. rezaie, r. et al. Brazilian health biotech-fostering crosstalk between public and private sectors. Nat. Biotechnol. 26, 627-644, 2008).
5. Rao, S. The rise of the BrICS: what does it mean for Canada? (Conference Board of Canada, 2008).
6. Wagner, C.S. The new invisible college: science for development (Brookings Institution, Washington, DC, 2008).
7. Thorsteinsdóttir, H., Saenz, T.W., Quach, u., Daar, a.S. & Singer, P.a. Cuba-innovation through synergy. Nat. Biotechnol. 22 (suppl.), DC19-DC24 (2004).
8. Chataway, J., Tait, J. & Wield, D. frameworks for pharmaceutical innovation in developing countries-the case of Indian pharma. Technol. Anal. Strateg. 19, 697-708 (2007).
9. Mytelka, L.K. Pathways and policies to (bio)pharma-ceutical innovation systems in developing countries. Ind. Innov. 13, 415-435 (2006).
10. Bower, J.D. & Sulej, J.C. The Indian challenge: the evolution of a successful new global strategy in the pharmaceutical industry. Technol. Anal. Strateg. 19, 611-624 (2007).
11. Thorsteinsdottir, H., Daar, a.S. & Singer, P.a. Health biotechnology publishing takes-off in developing coun-tries. Int. J. Biotechnol. 8, 23-42 (2006).
12. van Beuzekom, B. & arundel, a. OECD biotechnology statistics. (OECD, Paris, 2006).
13. Munn-Venn, T. & Mitchell, P. Biotechnology in Canada: a technology platform for growth (Conference Board of Canada, 2005).
14. Traore, N. Canadian biotech firms: extent of networking activities and commercialization success. Innov. Anal. Bull. 3, 13-14 (2001). Biotecanada. Canadian and uS biotechnology companies forging new partnerships at the 2007 Bio International Convention (May 2007).
15. Dufour, P. Taking the (right?) fork in the road: Canada?s two-track approach to domestic and international science and technology. Sci. Public Policy 29, 419-430 (2002).
16. Melon, C.C. et al. a survey of South-North health biotech collaboration. Nat. Biotechnol. 27, 229-232 (2009).
17. Zhenzhen, L. et al. Health biotechnology in China- reawakening of a giant. Nat. Biotechnol. 22 (suppl.), DC13-DC18 (2004).
18. Kumar, N.K. et al. Indian biotechnology-rapidly evolving and industry led. Nat. Biotechnol. 22 (suppl.), DC31-DC36 (2004)
19. ferrer, M., Thorsteinsdóttir, H., Quach, u., Singer, P.a. & Daar, a.S. The scientific muscle of Brazil?s health biotechnology. Nat. Biotechnol. 22 (suppl.), DC8-DC12 (2004).
20. Coe, D.T., Helpman, E. & Hoffmaister, a.W. North-south r&D spillovers. Econ. J. 107, 134-149 (1997).
21. Yusuf, S., Nabeshima, K. & Perkins, D.H. China and India reshape global industrial geography. in Dancing with Giants: China, India and the Global Economy. Pages 35-66. Editors: Winters, L.a. & Yusef, S. The World Bank: Washington, D.C. (2007).
22. Taylor, a.D. et al. North-South partnerships-a study of Canadian firms. Nat. Biotechnol. 25, 978-979 (2007)
23. Zhong, N.S. & Wong, G.W.K. Epidemiology of severe acute respiratory syndrome (SarS): adults and children. Paediatr. Respir. Rev. 5, 270-272 (2004).
24. Wild, S., roglic, G., Green, a., Sicree, r. & King, H. Estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053 (2004).